Global biopharmaceutical company
Enterprise-wide clinical data platform rollout across 40 markets
The challenge
A legacy data infrastructure was blocking regulatory submissions and slowing clinical trial timelines. The program had stalled twice under previous leadership with no clear path to delivery.
What we did
We restructured the program governance, established a phased release plan aligned to regulatory milestones, and embedded a delivery cadence that gave the business visibility at every stage. Cross-functional workstreams were coordinated across IT, clinical operations, and regulatory affairs.
Delivery model
Hybrid · 6 releases
Results